Cargando…
PB1900: COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS.
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430116/ http://dx.doi.org/10.1097/01.HS9.0000974424.53907.97 |
| _version_ | 1785090878753210368 |
|---|---|
| author | Saavedra, Minerva Montalvo Garcia, Alvaro Bienert Pérez-Pinilla, Belén González-Casanova, Paula Reyes Díaz-Lopez, Marta Quiroz, Jose Gregorio Torres Llorens, Alberto Martinez Goyeneche, Cielo de Los Ángeles Lorena Borja Higueras, Carolina Lacalzada González, Bernardo Javier González Garcia, Miguel Teodoro Hernandez Lakhwani, Sunil Lakhwani |
| author_facet | Saavedra, Minerva Montalvo Garcia, Alvaro Bienert Pérez-Pinilla, Belén González-Casanova, Paula Reyes Díaz-Lopez, Marta Quiroz, Jose Gregorio Torres Llorens, Alberto Martinez Goyeneche, Cielo de Los Ángeles Lorena Borja Higueras, Carolina Lacalzada González, Bernardo Javier González Garcia, Miguel Teodoro Hernandez Lakhwani, Sunil Lakhwani |
| author_sort | Saavedra, Minerva Montalvo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430116 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104301162023-08-17 PB1900: COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS. Saavedra, Minerva Montalvo Garcia, Alvaro Bienert Pérez-Pinilla, Belén González-Casanova, Paula Reyes Díaz-Lopez, Marta Quiroz, Jose Gregorio Torres Llorens, Alberto Martinez Goyeneche, Cielo de Los Ángeles Lorena Borja Higueras, Carolina Lacalzada González, Bernardo Javier González Garcia, Miguel Teodoro Hernandez Lakhwani, Sunil Lakhwani Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430116/ http://dx.doi.org/10.1097/01.HS9.0000974424.53907.97 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Saavedra, Minerva Montalvo Garcia, Alvaro Bienert Pérez-Pinilla, Belén González-Casanova, Paula Reyes Díaz-Lopez, Marta Quiroz, Jose Gregorio Torres Llorens, Alberto Martinez Goyeneche, Cielo de Los Ángeles Lorena Borja Higueras, Carolina Lacalzada González, Bernardo Javier González Garcia, Miguel Teodoro Hernandez Lakhwani, Sunil Lakhwani PB1900: COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS. |
| title | PB1900: COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS. |
| title_full | PB1900: COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS. |
| title_fullStr | PB1900: COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS. |
| title_full_unstemmed | PB1900: COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS. |
| title_short | PB1900: COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS. |
| title_sort | pb1900: combined treatment with venetoclax plus hypomethylating agent or cytarabine versus treatment with hypomethylating agent alone in acute myeloid leukemia in poor prognosis patients. |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430116/ http://dx.doi.org/10.1097/01.HS9.0000974424.53907.97 |
| work_keys_str_mv | AT saavedraminervamontalvo pb1900combinedtreatmentwithvenetoclaxplushypomethylatingagentorcytarabineversustreatmentwithhypomethylatingagentaloneinacutemyeloidleukemiainpoorprognosispatients AT garciaalvarobienert pb1900combinedtreatmentwithvenetoclaxplushypomethylatingagentorcytarabineversustreatmentwithhypomethylatingagentaloneinacutemyeloidleukemiainpoorprognosispatients AT perezpinillabelen pb1900combinedtreatmentwithvenetoclaxplushypomethylatingagentorcytarabineversustreatmentwithhypomethylatingagentaloneinacutemyeloidleukemiainpoorprognosispatients AT gonzalezcasanovapaulareyes pb1900combinedtreatmentwithvenetoclaxplushypomethylatingagentorcytarabineversustreatmentwithhypomethylatingagentaloneinacutemyeloidleukemiainpoorprognosispatients AT diazlopezmarta pb1900combinedtreatmentwithvenetoclaxplushypomethylatingagentorcytarabineversustreatmentwithhypomethylatingagentaloneinacutemyeloidleukemiainpoorprognosispatients AT quirozjosegregoriotorres pb1900combinedtreatmentwithvenetoclaxplushypomethylatingagentorcytarabineversustreatmentwithhypomethylatingagentaloneinacutemyeloidleukemiainpoorprognosispatients AT llorensalbertomartinez pb1900combinedtreatmentwithvenetoclaxplushypomethylatingagentorcytarabineversustreatmentwithhypomethylatingagentaloneinacutemyeloidleukemiainpoorprognosispatients AT goyenechecielodelosangeleslorenaborja pb1900combinedtreatmentwithvenetoclaxplushypomethylatingagentorcytarabineversustreatmentwithhypomethylatingagentaloneinacutemyeloidleukemiainpoorprognosispatients AT higuerascarolinalacalzada pb1900combinedtreatmentwithvenetoclaxplushypomethylatingagentorcytarabineversustreatmentwithhypomethylatingagentaloneinacutemyeloidleukemiainpoorprognosispatients AT gonzalezbernardojaviergonzalez pb1900combinedtreatmentwithvenetoclaxplushypomethylatingagentorcytarabineversustreatmentwithhypomethylatingagentaloneinacutemyeloidleukemiainpoorprognosispatients AT garciamiguelteodorohernandez pb1900combinedtreatmentwithvenetoclaxplushypomethylatingagentorcytarabineversustreatmentwithhypomethylatingagentaloneinacutemyeloidleukemiainpoorprognosispatients AT lakhwanisunillakhwani pb1900combinedtreatmentwithvenetoclaxplushypomethylatingagentorcytarabineversustreatmentwithhypomethylatingagentaloneinacutemyeloidleukemiainpoorprognosispatients |